FDA NDC Directory · JSON-LD · Markdown

DEFERASIROX

NDC 59651-447 · HUMAN PRESCRIPTION DRUG · GRANULE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA215137
Dosage form / routeGRANULE · ORAL
Active ingredientsDEFERASIROX (90 mg/1)
Marketing started20250908
Package count1

External sources

Source: openFDA. Public-domain (CC0).